Sökning: onr:"swepub:oai:DiVA.org:uu-147709" >
Warfarin Use and Ou...
Warfarin Use and Outcomes in Patients with Atrial Fibrillation Complicating Acute Coronary Syndromes
-
Lopes, Renato D. (författare)
-
Starr, Aijing (författare)
-
Pieper, Carl F. (författare)
-
visa fler...
-
Al-Khatib, Sana M. (författare)
-
Newby, L. Kristin (författare)
-
Mehta, Rajendra H. (författare)
-
Van de Werf, Frans (författare)
-
Mahaffey, Kenneth W. (författare)
-
Armstrong, Paul W. (författare)
-
Harrington, Robert A. (författare)
-
White, Harvey D. (författare)
-
- Wallentin, Lars (författare)
- Uppsala universitet,Uppsala kliniska forskningscentrum (UCR)
-
Granger, Christopher B. (författare)
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2010
- 2010
- Engelska.
-
Ingår i: American Journal of Medicine. - : Elsevier BV. - 0002-9343 .- 1555-7162. ; 123:2, s. 134-140
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND: We examined warfarin use at discharge (according to Congestive heart failure, Hypertension, Age > 75 years, Diabetes, Prior Stroke/transient ischemic attack score and bleeding risk) and its association with 6-month death or myocardial infarction in patients with post-acute coronary syndrome atrial fibrillation. METHODS: Of the 23,208 patients enrolled in the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy, Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network A, and Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors trials, 4.0% (917 patients) had atrial fibrillation as an in-hospital complication and were discharged alive. Cox proportional hazards models were performed to assess 6-month outcomes after discharge. RESULTS: Overall, 13.5% of patients with an acute coronary syndrome complicated by atrial fibrillation received warfarin at discharge. Warfarin use among patients with atrial fibrillation had no relation with estimated stroke risk; similar rates were observed across Congestive heart failure, Hypertension, Age > 75 years, Diabetes, Prior Stroke/transient ischemic attack (CHADS(2)) scores (0, 13%; 1, 14%: >= 2, 13%) and across different bleeding risk categories (low risk, 11.9%: intermediate risk, 13.3%; high risk, 11.1%). Among patients with in-hospital atrial fibrillation, warfarin use at discharge was independently associated with a lower risk of death or myocardial infarction within 6 months of discharge (hazard ratio 0.39; 95% confidence interval, 0.15-0.98). CONCLUSION: Warfarin is associated with better 6-month outcomes among patients with atrial fibrillation complicating an acute coronary syndrome, but its use is not related to CHADS(2) score or bleeding risk.
Nyckelord
- Acute coronary syndrome
- Antithrombotics
- Atrial fibrillation
- Bleeding risk
- MEDICINE
- MEDICIN
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Lopes, Renato D.
-
Starr, Aijing
-
Pieper, Carl F.
-
Al-Khatib, Sana ...
-
Newby, L. Kristi ...
-
Mehta, Rajendra ...
-
visa fler...
-
Van de Werf, Fra ...
-
Mahaffey, Kennet ...
-
Armstrong, Paul ...
-
Harrington, Robe ...
-
White, Harvey D.
-
Wallentin, Lars
-
Granger, Christo ...
-
visa färre...
- Artiklar i publikationen
-
American Journal ...
- Av lärosätet
-
Uppsala universitet